https://www.selleckchem.com/pr....oducts/6-aminonicoti
reported treatment effects. Fifty-seven percent of all trials will assess mortality as an outcome facilitating future meta-analyses. An extraordinary number of randomized clinical trials investigating COVID-19 management have been initiated with a multitude of medical preventive, adjunctive and treatment modalities. Blinding will be used in only 47% of trials, which may have influence on future reported treatment effects. Fifty-seven percent of all trials will assess mortality as an outcome facilitating future meta-analyses.
Like
Comment
Share
